Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Studies on steroid monooxygenase from Cylindrocarpon radicicola ATCC 11011. Purification and characterization
1986
Itagaki, E.
J. Biochem.
99
815-824
Lipid regulation of bovine cytochrome P45011beta activity
1990
Seybert, D.
Arch. Biochem. Biophys.
279
188-194
Regulation of synthesis and activity of NAD+-dependent 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells
1991
Xun, C.Q.; Ensor, C.M.; Tai, H.H.
Biochem. Biophys. Res. Commun.
177
1258-1265
Metabolism of 11-oxogenated steroids. Metabolism in vitro by preparations of liver
1968
Bush, I.E.; Hunter, S.A.; Meigs, R.A.
Biochem. J.
107
239-258
Purification and characterization of a novel form of 20alpha-hydroxysteroid dehydrogenase from Clostridium scindens
1989
Krafft, A.E.; Hylemon, P.B.
J. Bacteriol.
171
2925-2932
Cofactor requirements of steroid-17-20-desmolase and 20alpha-hydroxysteroid dehydrogenase ativities in cell extracts of Clostridium scindens
1987
Krafft, A.E.; Winter, J.; Bokkenheuser, V.D.; Hylemon, P.B.
J. Steroid Biochem.
28
49-54
The 21-hydroxysteroid dehydrogenases of liver. A nicotinamide adenine dinucleotide phosphate dehydrogenase and two nicotinamide adenine dinucleotide dehydrogenases
1965
Monder, C.; White, A.
J. Biol. Chem.
240
71-77
Properties of immobilized subunits of 20beta-hydroxysteroid dehydrogenase
1987
Carrea, G.; Pasta, P.
Methods Enzymol.
135
475-483
-
Enzyme-catalyzed steroid transformations in water-organic solvent two-phase systems
1987
Carrea, G.; Cremonesi, P.
Methods Enzymol.
136
150-157
Bifunctional enzyme activity at the same active site: study of 3alpha and 20beta activity by affinity alkylation of 3alpha, 20beta-hydroxysteroid dehydrogenase with 17-(bromoacetoxy)steroids
1980
Sweet, F.; Samant, B.R.
Biochemistry
19
978-986
Comparison of the 3alpha-and 20beta-hydroxysteroid dehydrogenase activities of the cortisone reductase of Streptomyces hydrogenans
1978
Edwards, C.A.F.; Orr, J.C.
Biochemistry
17
4370-4376
20beta-Hydroxysteroid oxidoreductase. Kinetics and binding of corticosteroids and corticosteroid-21-aldehydes
1977
Szymanski, E.S.; Furfine, C.S.
J. Biol. Chem.
252
205-211
Short-chain dehydrogenases. Proteolysis and chemical modification of prokaryotic 3alpha/20beta-hydroxysteroid, insect alcohol and human 15-hydroxyprostaglandin dehydrogenase
1992
Krook, M.; Prozorovski, V.; Atrian, S.; Gonzalez-Duarte, R.; Jörnvall, H.
Eur. J. Biochem.
209
233-239
20beta-Hydroxysteroid dehydrogenase catalyzes ketone-reduction of acetohexamide, an oral antidiabetic drug, in liver microsomes of adult male rats
1998
Takada, H.; Otagiri, M.; Imamura, Y.
J. Pharmacol. Exp. Ther.
287
504-507
Purification and properties of a 3alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs
1984
Penning, T.M.; Mukharji, I.; Barrows, S.; Talalay, P.
Biochem. J.
222
601-611
Purification and characterization of NADP+-dependent 3alpha-hydroxysteroid dehydrogenase from mouse liver cytosol
1988
Hara, A.; Inoue, Y.; Nakagawa, M.; Naganeo, F.; Sawada, H.
J. Biochem.
103
1027-1034
Identification of cortisone 5beta-reductase as DELTA4-3-ketosteroid 5beta-reductase
1987
Furuebisu, M.; Deguchi, S.; Okuda, K.
Biochim. Biophys. Acta
912
110-114
Purification and characterization of DELTA 4-3-ketosteroid 5beta-reductase
1984
Okuda, A.; Okuda, K.
J. Biol. Chem.
259
7519-7524
Separation of DELTA4-5alpha- and DELTA4-5beta-hydrogenases from rat liver homogenates
1956
Forchielli, E.; Dorfmann, R.I.
J. Biol. Chem.
223
443-448
Steroid DELTA4-reductases of pig liver: partial purification of testosterone 5beta-reductase
1971
Nduaguba, J.C.; Clark, A.F.
Can. J. Biochem.
49
385-392
The DELTA4-hydrogenases of guinea pig adrenal gland
1960
Brown-Grant, K.; Forchielli, E.; Dorfman, R.I.
J. Biol. Chem.
235
1317-1320
The enzymatic reduction of DELTA4-3-ketosteroids
1957
Tomkins, G.M.
J. Biol. Chem.
225
13-24
-
Some characteristics of the microsomal steroid reductase (5alpha) of rat liver
1960
McGuire, J.S.; Hollis, V.W.; Tomkins, G.M.
J. Biol. Chem.
235
3112-3117
Purification and characterization of 3-ketosteroid-delta 1-dehydrogenase from Nocardia corallina
1990
Itagaki, E.; Wakabayashi, T.; Hatta, T.
Biochim. Biophys. Acta
1038
60-67
Purification and characterization of the 3-ketosteroid-DELTA1-dehydrogenase of Arthrobacter simplex produced in Streptomyces lividans
1995
Choi, K.P.; Molnar, I.; Yamashita, M.; Murooka, Y.
J. Biochem.
117
1043-1049
Enzymatic sulfation of steroids. V. Partial purification and some properties of sulfotransferase III, the major glucocorticoid sulfotransferase of liver cytosol from male rats
1978
Singer, S.S.; Gebhart, J.; Hess, E.
Can. J. Biochem.
56
1028-1035
Enzymatic sulfation of steroids. XI. The extensive purification and some properties of hepatic sulfotransferase III from female rats
1980
Singer, S.S.; Bruns, L.
Can. J. Biochem.
58
660-666
The identity of alcohol sulfotransferases with hydroxysteroid sulfotransferases
1980
Lyon, E.S.; Jakoby, W.B.
Arch. Biochem. Biophys.
202
474-481
11 beta-Hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase
2002
Maser, E.; Volker, B.; Friebertshauser, J.
Biochemistry
41
2459-2465
Functional characterization of the human 11 beta-hydroxysteroid dehydrogenase 1B (11 beta-HSD 1B) variant
2003
Blum, A.; Raum, A.; Maser, E.
Biochemistry
42
4108-4117
Characterisation of 11beta-hydroxysteroid dehydrogenases in feline kidney and liver
2004
Schipper, L.; Spee, B.; Rothuizen, J.; Woutersen-van Nijnanten, F.; Fink-Gremmels, J.
Biochim. Biophys. Acta
1688
68-77
Expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer
2004
Zbankova, S.; Bryndova, J.; Kment, M.; Pacha, J.
Cancer Lett.
210
95-100
Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen
2003
Maser, E.; Friebertshauser, J.; Volker, B.
Chem. Biol. Interact.
143-144
435-448
The critical role of the N-terminus of 11beta-hydroxysteroid dehydrogenase type 1, as being encoded by exon 1, for enzyme stabilization and activity
2003
Blum, A.; Maser, E.
Chem. Biol. Interact.
143-144
469-480
Comparative enzymology of 11beta -hydroxysteroid dehydrogenase type 1 from glucocorticoid resistant (guinea pig) versus sensitive (human) species
2003
Shafqat, N.; Elleby, B.; Svensson, S.; Shafqat, J.; Jornvall, H.; Abrahmsen, L.; Oppermann, U.
J. Biol. Chem.
278
2030-2035
Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase
2004
Frick, C.; Atanasov, A.G.; Arnold, P.; Ozols, J.; Odermatt, A.
J. Biol. Chem.
279
31131-31138
Membrane protein isolation by in situ solubilization, partitioning and affinity adsorption in aqueous two-phase systems. Purification of the human type 1 11beta-hydroxysteroid dehydrogenase
2004
Roobol-Boza, M.; Dolby, V.; Doverskog, M.; Barrefelt, A.; Lindqvist, F.; Oppermann, U.C.; Kohler Van Alstine, K.; Tjerneld, F.
J. Chromatogr. A
1043
217-223
Purification and characterization of 7beta-hydroxysteroid dehydrogenase from rabbit liver microsomes
2004
Shiotsuki, H.; Maeda, Y.; Chijiiwa, K.
J. Steroid Biochem. Mol. Biol.
91
185-190
Purification of full-length recombinant human and rat type 1 11beta-hydroxysteroid dehydrogenases with retained oxidoreductase activities
2002
Nobel, C.S.I.; Dunas, F.; Abrahmsen, L.B.
Protein Expr. Purif.
26
349-356
The novel anticancer drug oracin: different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11beta-hydroxysteroid dehydrogenase type 1
2004
Wsol, V.; Szotakova, B.; Skalova, L.; Maser, E.
Toxicology
197
253-261
D-Tryptophan pyrrolase activity in the liver and the intestine of the rat
1972
Loh, H.H.; Berg, C.P.
J. Nutr.
102
1331-1339
Regulation of 11beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol
2003
Gomez-Sanchez, E.P.; Venkataseshu, G.; Chen, Y.J.; Liu, Y.; Zhou, M.Y.; Toroslu, C.; Romero, D.G.; Hughson, M.D.; de Rodriguez, A.; Gomez-Sanchez, C.E.
Am. J. Physiol. Endocrinol. Metab.
285
E272-E279
Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes
2005
Zhang, J.; Osslund, T.D.; Plant, M.H.; Clogston, C.L.; Nybo, R.E.; Xiong, F.; Delaney, J.M.; Jordan, S.R.
Biochemistry
44
6948-6957
The role of tyrosine 177 in human 11beta-hydroxysteroid dehydrogenase type 1 in substrate and inhibitor binding: an unlikely hydrogen bond donor for the substrate
2006
Kim, K.W.; Wang, Z.; Busby, J.; Tsuruda, T.; Chen, M.; Hale, C.; Castro, V.M.; Svensson, S.; Nybo, R.; Xiong, F.; Wang, M.
Biochim. Biophys. Acta
1764
824-830
Synthesis and biological evaluation of sulfonamidooxazoles and beta-keto sulfones: selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I
2005
Xiang, J.; Ipek, M.; Suri, V.; Massefski, W.; Pan, N.; Ge, Y.; Tam, M.; Xing, Y.; Tobin, J.F.; Xu, X.; Tam, S.
Bioorg. Med. Chem. Lett.
15
2865-2869
Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
2005
Olson, S.; Aster, S.D.; Brown, K.; Carbin, L.; Graham, D.W.; Hermanowski-Vosatka, A.; LeGrand, C.B.; Mundt, S.S.; Robbins, M.A.; Schaeffer, J.M.; Slossberg, L.H.; Szymonifka, M.J.; Thieringer, R.; Wright, S.D.; Balkovec, J.M.
Bioorg. Med. Chem. Lett.
15
4359-4362
In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance
2005
Mai, K.; Kullmann, V.; Bobbert, T.; Maser-Gluth, C.; Moehlig, M.; Baehr, V.; Pfeiffer, A.F.; Spranger, J.; Diederich, S.
Clin. Endocrinol. (Oxf.)
63
442-449
11beta Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle
2006
Jang, C.; Obeyesekere, V.R.; Dilley, R.J.; Alford, F.P.; Inder, W.J.
Clin. Endocrinol. (Oxf.)
65
800-805
Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity
2006
Basu, R.; Edgerton, D.S.; Singh, R.J.; Cherrington, A.; Rizza, R.A.
Diabetes
55
3013-3019
Enhancement of cortisol-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by interleukin 1beta in cultured human chorionic trophoblast cells
2006
Li, W.; Gao, L.; Wang, Y.; Duan, T.; Myatt, L.; Sun, K.
Endocrinology
147
2490-2495
Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis
2005
Claus, R.; Wagner, A.; Lambert, T.
Exp. Clin. Endocrinol. Diabetes
113
262-267
Coffee inhibits the reactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: a glucocorticoid connection in the anti-diabetic action of coffee?
2006
Atanasov, A.G.; Dzyakanchuk, A.A.; Schweizer, R.A.; Nashev, L.G.; Maurer, E.M.; Odermatt, A.
FEBS Lett.
580
4081-4085
The crystal structure of guinea pig 11beta-hydroxysteroid dehydrogenase type 1 provides a model for enzyme-lipid bilayer interactions
2005
Ogg, D.; Elleby, B.; Norstroem, C.; Stefansson, K.; Abrahmsen, L.; Oppermann, U.; Svensson, S.
J. Biol. Chem.
280
3789-3794
Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes
2006
McCormick, K.L.; Wang, X.; Mick, G.J.
J. Biol. Chem.
281
341-347
Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors
2006
Miguet, L.; Zhang, Z.; Barbier, M.; Grigorov, M.G.
J. Comput. Aided Mol. Des.
20
67-81
Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes
2006
Gilmour, J.S.; Coutinho, A.E.; Cailhier, J.F.; Man, T.Y.; Clay, M.; Thomas, G.; Harris, H.J.; Mullins, J.J.; Seckl, J.R.; Savill, J.S.; Chapman, K.E.
J. Immunol.
176
7605-7611
Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species
2005
Arampatzis, S.; Kadereit, B.; Schuster, D.; Balazs, Z.; Schweizer, R.A.; Frey, F.J.; Langer, T.; Odermatt, A.
J. Mol. Endocrinol.
35
89-101
11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women
2006
Ayachi, S.E.; Paulmyer-Lacroix, O.; Verdier, M.; Alessi, M.C.; Dutour, A.; Grino, M.
J. Thromb. Haemost.
4
621-627
Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1
2006
Odermatt, A.; Atanasov, A.G.; Balazs, Z.; Schweizer, R.A.; Nashev, L.G.; Schuster, D.; Langer, T.
Mol. Cell. Endocrinol.
248
15-23
Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase is based on a common pyridine nucleotide pool in the lumen of the endoplasmic reticulum
2006
Czegle, I.; Piccirella, S.; Senesi, S.; Csala, M.; Mandl, J.; Banhegyi, G.; Fulceri, R.; Benedetti, A.
Mol. Cell. Endocrinol.
248
24-25
Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons
2006
Hult, M.; Shafqat, N.; Elleby, B.; Mitschke, D.; Svensson, S.; Forsgren, M.; Barf, T.; Vallgarda, J.; Abrahmsen, L.; Oppermann, U.
Mol. Cell. Endocrinol.
248
26-33
11beta-Hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics
2006
Maser, E.; Wsol, V.; Martin, H.J.
Mol. Cell. Endocrinol.
248
34-37
Reductive and oxidative half-reactions of morphinone reductase from Pseudomonas putida M10: a kinetic and thermodynamic analysis
1998
Craig, D.H.; Moody, P.C.; Bruce, N.C.; Scrutton, N.S.
Biochemistry
37
7598-7607
Hormone induced expression of brush border lactase in suckling rat intestine
2008
Chaudhry, K.K.; Mahmood, S.; Mahmood, A.
Mol. Cell. Biochem.
312
11-16
Crystal structure of human liver DELTA4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis
2008
Di Costanzo, L.; Drury, J.E.; Penning, T.M.; Christianson, D.W.
J. Biol. Chem.
283
16830-16839
An in vitro microdialysis methodology to study 11beta-hydroxysteroid dehydrogenase type 1 enzyme activity in liver microsomes
2007
Sun, L.; Stenken, J.A.; Yang, A.Y.; Zhao, J.J.; Musson, D.G.
Anal. Biochem.
370
26-37
Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
2007
Flyren, K.; Bergquist, L.O.; Castro, V.M.; Fotsch, C.; Johansson, L.; St Jean, D.J.; Sutin, L.; Williams, M.
Bioorg. Med. Chem. Lett.
17
3421-3425
Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling
2008
Yang, H.; Dou, W.; Lou, J.; Leng, Y.; Shen, J.
Bioorg. Med. Chem. Lett.
18
1340-1345
Bis-aryl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
2008
Aster, S.D.; Graham, D.W.; Kharbanda, D.; Patel, G.; Ponpipom, M.; Santorelli, G.M.; Szymonifka, M.J.; Mundt, S.S.; Shah, K.; Springer, M.S.; Thieringer, R.; Hermanowski-Vosatka, A.; Wright, S.D.; Xiao, J.; Zokian, H.; Balkovec, J.M.
Bioorg. Med. Chem. Lett.
18
2799-2804
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
2008
Wang, H.; Ruan, Z.; Li, J.J.; Simpkins, L.M.; Smirk, R.A.; Wu, S.C.; Hutchins, R.D.; Nirschl, D.S.; Van Kirk, K.; Cooper, C.B.; Sutton, J.C.; Ma, Z.; Golla, R.; Seethala, R.; Salyan, M.E.; Nayeem, A.; Krystek, S.R.; Sheriff, S.; Camac, D.M.; Morin, P.E.; Carpenter, B.; Robl, J.A.; Zahler, R.; Gordon, D.A.; Hamann, L.G.
Bioorg. Med. Chem. Lett.
18
3168-3172
4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I
2008
Zhu, Y.; Olson, S.H.; Hermanowski-Vosatka, A.; Mundt, S.; Shah, K.; Springer, M.; Thieringer, R.; Wright, S.; Xiao, J.; Zokian, H.; Balkovec, J.M.
Bioorg. Med. Chem. Lett.
18
3405-3411
Phenylcyclobutyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I
2008
Zhu, Y.; Olson, S.H.; Graham, D.; Patel, G.; Hermanowski-Vosatka, A.; Mundt, S.; Shah, K.; Springer, M.; Thieringer, R.; Wright, S.; Xiao, J.; Zokian, H.; Dragovic, J.; Balkovec, J.M.
Bioorg. Med. Chem. Lett.
18
3412-3416
Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)
2008
Sun, D.; Wang, Z.; Di, Y.; Jaen, J.C.; Labelle, M.; Ma, J.; Miao, S.; Sudom, A.; Tang, L.; Tomooka, C.S.; Tu, H.; Ursu, S.; Walker, N.; Yan, X.; Ye, Q.; Powers, J.P.
Bioorg. Med. Chem. Lett.
18
3513-3516
The selectivity of tyrosine 280 of human 11beta-hydroxysteroid dehydrogenase type 1 in inhibitor binding
2007
Kim, K.W.; Wang, Z.; Busby, J.; Tsuruda, T.; Chen, M.; Hale, C.; Castro, V.M.; Svensson, S.; Nybo, R.; Xiong, F.; Wang, M.
FEBS Lett.
581
995-999
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice
2008
Johansson, L.; Fotsch, C.; Bartberger, M.D.; Castro, V.M.; Chen, M.; Emery, M.; Gustafsson, S.; Hale, C.; Hickman, D.; Homan, E.; Jordan, S.R.; Komorowski, R.; Li, A.; McRae, K.; Moniz, G.; Matsumoto, G.; Orihuela, C.; Palm, G.; Veniant, M.; Wang, M.; Williams, M.; Zhang, J.
J. Med. Chem.
51
2933-2943
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model
2008
Julian, L.D.; Wang, Z.; Bostick, T.; Caille, S.; Choi, R.; Degraffenreid, M.; Di, Y.; He, X.; Hungate, R.W.; Jaen, J.C.; Liu, J.; Monshouwer, M.; McMinn, D.; Rew, Y.; Sudom, A.; Sun, D.; Tu, H.; Ursu, S.; Walker, N.; Yan, X.; Ye, Q.; Powers, J.P.
J. Med. Chem.
51
3953-3960
5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1
2007
Hennebert, O.; Le Mee, S.; Pernelle, C.; Morfin, R.
Steroids
72
855-864
Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids
2009
Endo, S.; Matsunaga, T.; Mamiya, H.; Ohta, C.; Soda, M.; Kitade, Y.; Tajima, K.; Zhao, H.T.; El-Kabbani, O.; Hara, A.
Arch. Biochem. Biophys.
487
1-9
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1
2008
Tu, H.; Powers, J.P.; Liu, J.; Ursu, S.; Sudom, A.; Yan, X.; Xu, H.; Meininger, D.; Degraffenreid, M.; He, X.; Jaen, J.C.; Sun, D.; Labelle, M.; Yamamoto, H.; Shan, B.; Walker, N.P.; Wang, Z.
Bioorg. Med. Chem.
16
8922-8931
The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-HSD1 inhibitors
2008
Saiah, E.
Curr. Med. Chem.
15
642-649
11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets
2008
Swali, A.; Walker, E.A.; Lavery, G.G.; Tomlinson, J.W.; Stewart, P.M.
Diabetologia
51
2003-2011
Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1
2008
Balachandran, A.; Guan, H.; Sellan, M.; van Uum, S.; Yang, K.
Endocrinology
149
4069-4079
Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors
2009
Yang, H.; Shen, Y.; Chen, J.; Jiang, Q.; Leng, Y.; Shen, J.
Eur. J. Med. Chem.
44
1167-1171
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines
2009
Gumy, C.; Thurnbichler, C.; Aubry, E.M.; Balazs, Z.; Pfisterer, P.; Baumgartner, L.; Stuppner, H.; Odermatt, A.; Rollinger, J.M.
Fitoterapia
80
200-205
Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children
2009
Mericq, V.; Medina, P.; Bouwman, C.; Johnson, M.C.; Godoy, J.; Lopez, T.; Iniguez, G.
Horm. Res.
71
89-93
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model
2009
Wan, Z.K.; Chenail, E.; Xiang, J.; Li, H.Q.; Ipek, M.; Bard, J.; Svenson, K.; Mansour, T.S.; Xu, X.; Tian, X.; Suri, V.; Hahm, S.; Xing, Y.; Johnson, C.E.; Li, X.; Qadri, A.; Panza, D.; Perreault, M.; Tobin, J.F.; Saiah, E.
J. Med. Chem.
52
5449-5461
The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response
2009
Chapman, K.E.; Coutinho, A.E.; Gray, M.; Gilmour, J.S.; Savill, J.S.; Seckl, J.R.
Mol. Cell. Endocrinol.
301
123-131
Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1)
2009
Di Costanzo, L.; Drury, J.E.; Christianson, D.W.; Penning, T.M.
Mol. Cell. Endocrinol.
301
191-198
Derivatives of (phenylsulfonamido-methyl)nicotine and (phenylsulfonamido-methyl)thiazole as novel 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: synthesis and biological activities in vitro
2009
Zhang, X.; Zhou, Y.; Shen, Y.; Du, L.L.; Chen, J.H.; Leng, Y.; Shen, J.H.
Acta Pharmacol. Sin.
30
1344-1350
Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors
2009
Cho, Y.S.; Kim, C.H.; Cheon, H.G.
Anal. Biochem.
392
110-116
Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)
2009
Sun, D.; Wang, Z.; Cardozo, M.; Choi, R.; Degraffenreid, M.; Di, Y.; He, X.; Jaen, J.C.; Labelle, M.; Liu, J.; Ma, J.; Miao, S.; Sudom, A.; Tang, L.; Tu, H.; Ursu, S.; Walker, N.; Yan, X.; Ye, Q.; Powers, J.P.
Bioorg. Med. Chem. Lett.
19
1522-1527
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275
2009
Siu, M.; Johnson, T.O.; Wang, Y.; Nair, S.K.; Taylor, W.D.; Cripps, S.J.; Matthews, J.J.; Edwards, M.P.; Pauly, T.A.; Ermolieff, J.; Castro, A.; Hosea, N.A.; LaPaglia, A.; Fanjul, A.N.; Vogel, J.E.
Bioorg. Med. Chem. Lett.
19
3493-3497
4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice
2009
Zhang, X.; Zhou, Z.; Yang, H.; Chen, J.; Feng, Y.; Du, L.; Leng, Y.; Shen, J.
Bioorg. Med. Chem. Lett.
19
4455-4458
Discovery of cyclicsulfonamide derivatives as 11beta-hydroxysteroid dehydrogenase 1 inhibitors
2010
Kim, S.H.; Ramu, R.; Kwon, S.W.; Lee, S.H.; Kim, C.H.; Kang, S.K.; Rhee, S.D.; Bae, M.A.; Ahn, S.H.; Ha, D.C.; Cheon, H.G.; Kim, K.Y.; Ahn, J.H.
Bioorg. Med. Chem. Lett.
20
1065-1069
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11beta-hydroxysteroid dehydrogenase 2 inhibitors
2010
Stanetty, C.; Czollner, L.; Koller, I.; Shah, P.; Gaware, R.; Cunha, T.D.; Odermatt, A.; Jordis, U.; Kosma, P.; Classen-Houben, D.
Bioorg. Med. Chem.
18
7522-7541
Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice
2010
Feng, Y.; Huang, S.L.; Dou, W.; Zhang, S.; Chen, J.H.; Shen, Y.; Shen, J.H.; Leng, Y.
Br. J. Pharmacol.
161
113-126
Sesquiterpenes from cultures of the basidiomycete Clitocybe conglobata and their 11 beta-hydroxysteroid dehydrogenase inhibitory activity
2009
Xu, D.; Sheng, Y.; Zhou, Z.Y.; Liu, R.; Leng, Y.; Liu, J.K.
Chem. Pharm. Bull.
57
433-435
Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors
2010
Su, X.; Pradaux-Caggiano, F.; Thomas, M.P.; Szeto, M.W.; Halem, H.A.; Culler, M.D.; Vicker, N.; Potter, B.V.
ChemMedChem
5
1026-1044
11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development
2010
Ge, R.; Huang, Y.; Liang, G.; Li, X.
Curr. Med. Chem.
17
412-422
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition
2010
Torres-Piedra, M.; Ortiz-Andrade, R.; Villalobos-Molina, R.; Singh, N.; Medina-Franco, J.L.; Webster, S.P.; Binnie, M.; Navarrete-Vazquez, G.; Estrada-Soto, S.
Eur. J. Med. Chem.
45
2606-2612
Diazepane-acetamide derivatives as selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
2009
Odermatt, A.
Expert Opin. Ther. Pat.
19
1477-1483
Pentanol derivatives from basidiomycete Catathelasma imperiale and their 11beta-hydroxysteroid dehydrogenases inhibitory activity
2009
Zhang, L.; Shen, Y.; Zhu, H.J.; Wang, F.; Leng, Y.; Liu, J.K.
J. Antibiot.
62
239-242
Fenofibrate but not fenofibric acid inhibits 11beta-hydroxysteroid dehydrogenase 1 in C2C12 myotubes
2010
Kim, C.H.; Ramu, R.; Ahn, J.H.; Bae, M.A.; Cho, Y.S.
Mol. Cell. Biochem.
344
91-98
Rare merosesquiterpenoids from basidiomycete Craterellus odoratus and their inhibition of 11beta-hydroxysteroid dehydrogenases
2010
Zhang, L.; Shen, Y.; Wang, F.; Leng, Y.; Liu, J.K.
Phytochemistry
71
100-103
Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency
2010
Drury, J.E.; Mindnich, R.; Penning, T.M.
J. Biol. Chem.
285
24529-24537
Discovery of a novel enzyme mediating glucocorticoid catabolism in fish: 20beta-hydroxysteroid dehydrogenase type 2
2012
Tokarz, J.; Mindnich, R.; Norton, W.; Moeller, G.; Hrabe de Angelis, M.; Adamski, J.
Mol. Cell. Endocrinol.
349
202-213
Substrate specificity and inhibitor analyses of human steroid 5beta-reductase (AKR1D1)
2011
Chen, M.; Drury, J.E.; Penning, T.M.
Steroids
76
484-490
11beta-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes
2013
Itoi, S.; Terao, M.; Murota, H.; Katayama, I.
Biochem. Biophys. Res. Commun.
440
265-270
Biological roles of hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), HSD11B2, and glucocorticoid receptor (NR3C1) in sheep conceptus elongation
2015
Brooks, K.; Burns, G.; Spencer, T.E.
Biol. Reprod.
93
38
Synthesis and biological analysis of benzazol-2-yl piperazine sulfonamides as 11beta-hydroxysteroid dehydrogenase 1 inhibitors
2013
Hofer, S.; Kratschmar, D.V.; Schernthanner, B.; Vuorinen, A.; Schuster, D.; Odermatt, A.; Easmon, J.
Bioorg. Med. Chem. Lett.
23
5397-5400
3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11beta-hydroxysteroid dehydrogenase 1 inhibitor
2014
Lee, Y.; Shin, Y.J.; Ahn, S.K.
Bioorg. Med. Chem. Lett.
24
1421-1425
Synthesis and biological evaluation of picolinamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)
2015
Ryu, J.H.; Kim, S.; Han, H.Y.; Son, H.J.; Lee, H.J.; Shin, Y.A.; Kim, J.S.; Park, H.G.
Bioorg. Med. Chem. Lett.
25
695-700
11beta-Hydroxysteroid dehydrogenase type 1 is expressed in neutrophils and restrains an inflammatory response in male mice
2016
Coutinho, A.E.; Kipari, T.M.; Zhang, Z.; Esteves, C.L.; Lucas, C.D.; Gilmour, J.S.; Webster, S.P.; Walker, B.R.; Hughes, J.; Savill, J.S.; Seckl, J.R.; Rossi, A.G.; Chapman, K.E.
Endocrinology
157
2928-2936
11beta-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes
2015
Dube, S.; Norby, B.J.; Pattan, V.; Carter, R.E.; Basu, A.; Basu, R.
J. Clin. Endocrinol. Metab.
100
E70-E76
Resveratrol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes
2013
Tagawa, N.; Kubota, S.; Kato, I.; Kobayashi, Y.
J. Endocrinol.
218
311-320
Medicinal chemistry of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)
2014
Scott, J.S.; Goldberg, F.W.; Turnbull, A.V.
J. Med. Chem.
57
4466-4486
11beta-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story
2015
Odermatt, A.; Klusonova, P.
J. Steroid Biochem. Mol. Biol.
151
85-92
Endocrine disruptors and other inhibitors of 11beta-hydroxysteroid dehydrogenase 1 and 2: Tissue-specific consequences of enzyme inhibition
2016
Vitku, J.; Starka, L.; Bicikova, M.; Hill, M.; Heracek, J.; Sosvorova, L.; Hampl, R.
J. Steroid Biochem. Mol. Biol.
155
207-216
11beta-Hydroxysteroid dehydrogenase enzymes modulate effects of glucocorticoids in rheumatoid arthritis synovial cells
2015
Schmidt, M.; Straub, R.H.
Neuroimmunomodulation
22
40-45
Metabolic coupling determines the activity: comparison of 11beta-hydroxysteroid dehydrogenase 1 and its coupling between liver parenchymal cells and testicular Leydig cells
2015
Li, X.; Hu, G.; Li, X.; Wang, Y.Y.; Hu, Y.Y.; Zhou, H.; Latif, S.A.; Morris, D.J.; Chu, Y.; Zheng, Z.; Ge, R.S.
PLoS ONE
10
e0141767
Green tea and one of its constituents, epigallocatechine-3-gallate, are potent inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1
2014
Hintzpeter, J.; Stapelfeld, C.; Loerz, C.; Martin, H.J.; Maser, E.
PLoS ONE
9
e84468
Species differences of 11beta-hydroxysteroid dehydrogenase type 2 function in human and rat term placenta determined via LC-MS/MS
2016
Heussner, K.; Ruebner, M.; Huebner, H.; Rascher, W.; Menendez-Castro, C.; Hartner, A.; Fahlbusch, F.B.; Rauh, M.
Placenta
37
79-84
Comparison of CYP106A1 and CYP106A2 from Bacillus megaterium - identification of a novel 11-oxidase activity
2015
Kiss, F.M.; Schmitz, D.; Zapp, J.; Dier, T.K.; Volmer, D.A.; Bernhardt, R.
Appl. Microbiol. Biotechnol.
99
8495-8514
DELTA4-3-ketosteroids as a new class of substrates for the cytosolic sulfotransferases
2017
Hashiguchi, T.; Kurogi, K.; Shimohira, T.; Teramoto, T.; Liu, M.C.; Suiko, M.; Sakakibara, Y.
Biochim. Biophys. Acta
1861
2883-2890
A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11beta-hydroxysteroid dehydrogenase type 1
2018
Studzinska, R.; Kolodziejska, R.; Kupczyk, D.; Plazinski, W.; Kosmalski, T.
Bioorg. Chem.
79
115-121
Thiazolo[3,2-a]pyrimidin-5-one derivatives as a novel class of 11beta-hydroxysteroid dehydrogenase inhibitors
2018
Studzinska, R.; Kupczyk, D.; Plazinska, A.; Kolodziejska, R.; Kosmalski, T.; Modzelewska-Banachiewicz, B.
Bioorg. Chem.
81
21-26
Design, synthesis, and biological evaluation of novel selective peptide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
2018
Boudon, S.; Heidl, M.; Vuorinen, A.; Wandeler, E.; Campiche, R.; Odermatt, A.; Jackson, E.
Bioorg. Med. Chem.
26
5128-5139
Expression and activity of the cortisol-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 is tissue and species-specific
2019
Dammann, C.; Stapelfeld, C.; Maser, E.
Chem. Biol. Interact.
303
57-61
Discovery and biological evaluation of potent and orally active human 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes mellitus
2019
Koike, T.; Shiraki, R.; Sasuga, D.; Hosaka, M.; Kawano, T.; Fukudome, H.; Kurosawa, K.; Moritomo, A.; Mimasu, S.; Ishii, H.; Yoshimura, S.
Chem. Pharm. Bull.
67
824-838
The role and regulation of the 11 beta-hydroxysteroid dehydrogenase enzyme system in patients with inflammatory bowel disease
2017
Hussey, M.; Holleran, G.; Smith, S.; Sherlock, M.; McNamara, D.
Digest. Dis. Sci.
62
3385-3390
Structural assessment and identification of 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
2020
Ganjoo, A.; Tripathi, A.; Chetti, P.
J. Biomol. Struct. Dyn.
38
4928-4937
11beta-Hydroxysteroid dehydrogenases control access of 7beta,27-dihydroxycholesterol to retinoid-related orphan receptor gamma
2019
Beck, K.R.; Inderbinen, S.G.; Kanagaratnam, S.; Kratschmar, D.V.; Jetten, A.M.; Yamaguchi, H.; Odermatt, A.
J. Lipid Res.
60
1535-1546
The cortisol-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome
2017
Loerz, C.; Maser, E.
J. Steroid Biochem. Mol. Biol.
174
65-71
Enzymatic interconversion of the oxysterols 7beta,25-dihydroxycholesterol and 7-keto,25-hydroxycholesterol by 11beta-hydroxysteroid dehydrogenase type 1 and 2
2019
Beck, K.R.; Kanagaratnam, S.; Kratschmar, D.V.; Birk, J.; Yamaguchi, H.; Sailer, A.W.; Seuwen, K.; Odermatt, A.
J. Steroid Biochem. Mol. Biol.
190
19-28
Design, synthesis, molecular docking and in vitro evaluation of benzothiazole derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
2020
Cabrera Perez, L.C.; Padilla-Martinez, I.I.; Cruz, A.; Correa Basurto, J.; Miliar Garcia, A.; Hernandez Zavala, A.A.; Gomez Lopez, M.; Rosales Hernandez, M.C.
Mol. Divers.
24
971-984
Role of 11beta-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis
2020
Lee, N.R.; Kim, B.J.; Lee, C.H.; Lee, Y.B.; Lee, S.; Hwang, H.J.; Kim, E.; Kim, S.H.; Lee, M.G.; Lee, S.E.; Lavery, G.G.; Choi, E.H.
Sci. Rep.
10
20237
Species-specific differences in the inhibition of 11beta-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole
2021
Inderbinen, S.G.; Zogg, M.; Kley, M.; Smiesko, M.; Odermatt, A.
Toxicol. Appl. Pharmacol.
412
115387